Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?

Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?

Background: The use of continuing antipsychotic medication is an established evidence-based strategy for preventing relapse in people with schizophrenia, but medication adherence is known to be suboptimal. Covert non-adherence can be eliminated by the use of long-acting injectable (LAI) formulations...

Full description

Bibliographic Details
Main Authors: Carol Paton, Chike I. Okocha, Maxine X. Patel
Format: Article
Language:English
Published: SAGE Publishing 2022-02-01
Series:Therapeutic Advances in Psychopharmacology
Online Access:https://doi.org/10.1177/20451253211072347

Similar Items

Similar Items